secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2023-07-14T23:59:59+00:00
Accession:  0001493152-23-024537
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

MyMD still awaiting Phase 2 data for MYMD-1 sarcopenia trial completed June 2023
--------------------------------------------------------------------------------

- Phase 2 trial of MYMD-1 for sarcopenia completed in June 2023; data not received as of July 14.
- No guidance on timing of data release; company states it is 'still awaiting receipt.'
- No other material updates in this filing; stock trades on Nasdaq under ticker MYMD.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315223024537/0001493152-23-024537-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315223024537/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-024537

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer